Treatment | CYP2B1 mRNA | CYP3A23 mRNA | |
---|---|---|---|
fold-increase relative to control | |||
P. ginseng Extract (μg/ml) | |||
0.1 | 0.78 ± 0.05 | 0.98 ± 0.14 | |
1 | 0.86 ± 0.08 | 0.92 ± 0.02 | |
10 | 0.95 ± 0.23 | 0.96 ± 0.21 | |
100 | 0.93 ± 0.27 | 0.79 ± 0.01 | |
1000 | 0.51 ± 0.25 | 0.31 ± 0.10* | |
P. quinquefolius Extract (μg/ml) | |||
0.1 | 0.84 ± 0.11 | 0.78 ± 0.01 | |
1 | 0.78 ± 0.07 | 0.60 ± 0.08 | |
10 | 0.88 ± 0.14 | 0.72 ± 0.06 | |
100 | 1.16 ± 0.26 | 1.00 ± 0.20 | |
1000 | 0.47 ± 0.11* | 0.87 ± 0.14 | |
PB (100 μM) | 49 ± 22* | not determined | |
DEX (10 μM) | not determined | 41 ± 2* |
↵* Significantly different from the corresponding vehicle-treated control group (p < 0.05).